UPC CoA 810/2024
Dec 13, 2024·EP2697391 · METHOD AND PRODUCT FOR LOCALISED OR SPATIAL DETECTION OF NUCLEIC ACID IN A TISSUE SAMPLE
- Case details
- StatusCase Closed (Claim dismissed)ActionAppealCategoryMain appeal
- Parties
- Claimants
- Curio Bioscience Inc.Operating co.
Representatives- Cameron Marshall-Carpmaels & Ransford
- Agathe Michel-De Cazotte-Carpmaels & Ransford
Respondents- 10x Genomics, Inc.Operating co.
Representatives- Tilman Mueller-Stoy-Bardehle Pagenberg
- Axel Berger-Bardehle Pagenberg
- Division
- Court of Appeal
- Judges
- Technology
- ChemistryBiotechnology
- Language
- English
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Judge Emmanuel Gougé | Locked |
At the UPC: Curio Bioscience Inc. (19 cases)·10x Genomics, Inc. (40 cases)
This dispute contains 18 other proceedings
UPC CFI 657/2025·UPC CFI 658/2025·UPC CoA 805/2024·UPC CoA 234/2024·UPC CFI 140/2024 and 13 more
Start a free trial to see how each one ended.
More cases: Court of Appeal·2024
- 2024-12-17Application RoP 223Public
Summary: The Court of Appeal (standing judge) dismissed Curio Bioscience Inc.'s application for suspensive effect (R. 223.4 RoP) of a Düsseldorf Local Division order requiring Curio to provide security for costs of EUR 200,000 in favour of claimant 10x Genomics Inc. The standing judge held that Curio had not established 'extreme urgency' as required under R. 223 RoP, which is a condition for a standing-judge decision without hearing the respondent.
Show the legal issues (3)
- Application for suspensive effect (R. 223.4 RoP)
- Extreme urgency requirement
- Security for costs (R. 158 RoP / Art. 41(1) UPCA)
| Document title | Date | Public |
|---|---|---|
| Case closed | 2025-10-24 | Not public |
| Outcome of the Order | 2024-12-17 | Not public |
| Order | 2024-12-17 | Public |
| Panel-Appointment | 2024-12-16 | Not public |
| Receipt | 2024-12-16 | Not public |
| Exhibit | 2024-12-16 | Not public |
| Application | 2024-12-16 | Not public |